Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Hess Corp. Closes $1 Bln Sale Of Stake In ACG Fields To ONGC Videsh

RELATED NEWS
Trade HES now with 

Hess Corp (HES: Quote), an independent energy company on Thursday said that it has completed the sale totaling $1 billion of its 2.72 percent stake in the Azeri, Chirag and Guneshli Fields and its 2.36 percent stake in the associated BTC pipeline to ONGC Videsh Ltd.

John Hess, Chairman and Chief Executive of Hess, stated, "This sale is another step in the execution of our strategy to become a more focused, higher growth, lower risk pure play exploration and production company, the after tax net proceeds from this sale will be used to pay down an equivalent amount of short term debt."

Click here to receive FREE breaking news email alerts for Hess Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After moving moderately lower in early trading on Monday, stocks have seen further downside as the trading day has progressed. With the drop on the day, the Dow has pulled back well off last Friday's record closing high. After reporting four consecutive monthly increases, the National Association of Realtors released a report on Monday showing an unexpected drop in U.S. existing home sales in the month of August. NAR said existing home sales fell 1.8 percent to a seasonally adjusted annual rate of 5.05 million in August. The European Central Bank remains ready to use additional unconventional tools to counter risks to the inflation outlook and to boost the euro area economy, ECB President Mario Draghi said on Monday. "The Governing Council remains fully determined to counter risks to the medium-term outlook for inflation," Draghi said in Brussels.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.